Myostatin and muscle atrophy during chronic kidney disease

Chronic kidney disease (CKD) patients often exhibit a low muscle mass and strength, leading to physical impairment and an increased mortality. Two major signalling pathways control protein synthesis, the insulin-like growth factor-1/Akt (IGF-1/Akt) pathway, acting as a positive regulator, and the my...

Celý popis

Podrobná bibliografia

Vydané v:	Nephrology, dialysis, transplantation Ročník 36; číslo 11; s. 1986
Hlavní autori:	Bataille, Stanislas, Chauveau, Philippe, Fouque, Denis, Aparicio, Michel, Koppe, Laetitia
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 09.11.2021
Predmet:	Humans Muscle, Skeletal Muscular Atrophy - etiology Myostatin Renal Dialysis Renal Insufficiency, Chronic - therapy Uremic Toxins wasting chronic kidney disease myostatin sarcopenia
ISSN:	1460-2385, 1460-2385
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!